Key Drivers
- Margin Collapse
- Rising Leverage
- Cash Decline
AIAI Summary
AHCO is a high-risk turnaround, not a cheap growth story: investors should wait for several quarters of stable capitated-contract margins and positive free-cash-flow conversion, while monitoring whether diabetes-sale proceeds reduce leverage rather than fund ongoing execution gaps.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Collapse
- •Rising Leverage
- •Cash Decline
AHCO appears statistically cheap, but severe margin compression, widening losses, rising leverage, and negative free cash flow make it a high-risk turnaround rather than a clear value opportunity.
Price Behavior
Key Price Behavior Insights:
- •Weakening momentum
- •Key support
- •Overhead resistance
AHCO is weakening below its last-month average, with $5.50–$5.60 support critical and $6.04–$6.06 resistance limiting upside.
Severe drop from above $10.80 in early
Sentiment & News
Key News Insights:
- •New CFO
- •Transition Support
- •Investor Conference
AdaptHealth appointed Harriss T. Currie as CFO while maintaining investor engagement through an upcoming Jefferies conference.
The leadership transition may draw investor attention, while conference participation supports continued market outreach
Similar Companies in Healthcare
Other companies in the same sector with AI ratings